SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 30.96 |
| Enterprise Value ($M) | 130.54 |
| Book Value ($M) | -174.93 |
| Book Value / Share | -2.15 |
| Price / Book | -0.18 |
| NCAV ($M) | -191.61 |
| NCAV / Share | -1.90 |
| Price / NCAV | -0.16 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.98 |
| Current Ratio | 2.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 148.53 |
| Assets | 165.21 |
| Liabilities | 340.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 29.62 |
| Operating Income | -130.96 |
| Net Income | -47.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -138.00 |
| Cash from Investing | 125.99 |
| Cash from Financing | -0.26 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 8.42 | 25.00 | |
| 13G/A | Primecap Management Co/ca/ | 4.58 | -53.43 | |
| 13G/A | Vanguard Group Inc | 5.85 | 0.00 | |
| 13G/A | BlackRock, Inc. | 2.40 | -66.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 219,053 | 496,890 | 44.08 | |
| 83,009 | 305,642 | 27.16 | |
| 176,940 | 695,756 | 25.43 | |
| 292,101 | 1,087,460 | 26.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EWTX – Edgewise Therapeutics, Inc. | EXEL – Exelixis, Inc. |
| FDMT – 4D Molecular Therapeutics, Inc. | GBIO – Generation Bio Co. |
| GERN – Geron Corporation |
Financial data and stock pages provided by
Fintel.io